Price: $9.7
· 1 day: -1.12% · 5 days: +8.99% · 1 month: +1.57% · YTD: -46.82%
As of 2026-09-23 20:00 UTC.
52-week range: $7.21 – $20.46 (currently at 19% of the range).
The read
ADMA is in a turning down, momentum firm. $10 is the level overhead; $9.26 the first support below.
3 of 6 technical checks lean bullish.
Price vs 50-day: above
Price vs 200-day: below
50d vs 200d avg: below
MACD: bullish
RSI momentum: 54
5-day tape: +9.0%
Trend
Turning down · above 50-day & below 200-day
Momentum
RSI 53.91 · neutral · MACD bullish
Trend strength
ADX 19.5 · weak or range
Location
+5.0% vs 50-day MA
52-week range
-52% from high · +28% from low
Volatility
ATR 0.32 · ~3.3%/day
Key levels
Level
Type
Distance
$10.0 (resistance)
round
3.09%
$11.0 (resistance)
round
13.4%
$12.1 (resistance)
sma 200
24.74%
$9.26 (support)
swing zone
-4.54%
$9.0 (support)
round
-7.22%
$8.2 (support)
swing zone
-15.46%
Indicators
RSI (14)
53.91
MACD
0.0218
ADX (14)
19.5
ATR (14)
0.32
50-day average
$9.24
200-day average
$12.1
Next earnings: 2026-11-04.
Latest ADMA news
ADMA BIOLOGICS, INC. — Quarterly report (10-Q) — ADMA Biologics, Inc. filed its quarterly report on Form 10-Q with the SEC on August 5, 2026, for the second quarter of fiscal year 2026 ended June 30, 2026. The company reported revenue of $124.4 million, representing a (SEC EDGAR, 2026-08-05)